Literature DB >> 12801103

Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.

S Conroy1.   

Abstract

UNLABELLED: The lack of availability of licensed paediatric medicines forces pharmacists to compound drugs into a form that children can tolerate. There is a lack of information to support much of this practice and standards tend to vary. Suitable licensed alternatives are often available in other countries but importing restrictions complicate obtaining them.
CONCLUSION: Regulatory action is needed to simplify licensing and importation processes to facilitate universal access to suitable paediatric medicines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801103     DOI: 10.1111/j.1651-2227.2003.tb00568.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  6 in total

1.  How well are general practice trainees prepared for paediatric prescribing?

Authors:  N M Isa; Michael W Taylor; Peter J Helms; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2008-11-24       Impact factor: 4.335

2.  Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine.

Authors:  Maher R Khdour; Hussein Othman Hallak; Kawther Shab'an Atallah Alayasa; Qusai Nabeel AlShahed; Ahmed F Hawwa; James C McElnay
Journal:  Int J Clin Pharm       Date:  2011-05-13

Review 3.  A literature review on off-label drug use in children.

Authors:  Chiara Pandolfini; Maurizio Bonati
Journal:  Eur J Pediatr       Date:  2005-05-24       Impact factor: 3.183

4.  Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil.

Authors:  Djanilson Barbosa Santos; Antonio Clavenna; Maurizio Bonati; Helena Lutescia Luna Coelho
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

5.  Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.

Authors:  Hudson C Polonini; Sharlene L Silva; Thalyta R de Almeida; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-03-24

Review 6.  Dosage and formulation issues: oral vitamin E therapy in children.

Authors:  Tone Westergren; Betty Kalikstad
Journal:  Eur J Clin Pharmacol       Date:  2009-10-13       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.